The 83 rating InvestorsObserver gives to Urogen Pharma Ltd (URGN) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 99 percent of stocks in the Biotechnology industry, URGN’s 83 overall rating means the stock scores better than 83 percent of all stocks.
URGN has an Overall Score of 83. Find out what this means to you and get the rest of the rankings on URGN!
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 83 would rank higher than 83 percent of all stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Urogen Pharma Ltd Stock Today?
Urogen Pharma Ltd (URGN) stock has gained 5.37% while the S&P 500 is down -0.25% as of 11:39 AM on Friday, Aug 18. URGN is higher by $0.99 from the previous closing price of $18.43 on volume of 230,998 shares. Over the past year the S&P 500 is up 1.77% while URGN is higher by 137.41%. URGN lost -$4.71 per share the over the last 12 months.
Click Here to get the full Stock Report for Urogen Pharma Ltd stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
